KR20240090982A - 이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도 - Google Patents

이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도 Download PDF

Info

Publication number
KR20240090982A
KR20240090982A KR1020247017445A KR20247017445A KR20240090982A KR 20240090982 A KR20240090982 A KR 20240090982A KR 1020247017445 A KR1020247017445 A KR 1020247017445A KR 20247017445 A KR20247017445 A KR 20247017445A KR 20240090982 A KR20240090982 A KR 20240090982A
Authority
KR
South Korea
Prior art keywords
formula
tritium
deuterium
hydrogen
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247017445A
Other languages
English (en)
Korean (ko)
Inventor
린이 천
이 왕
원-링 랴오
위-탕 리
팅-쉬안 뤼
위-원 황
자-웨이 리
전 왕
팡-이 천
촨-진 자오
Original Assignee
린이 천
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 린이 천 filed Critical 린이 천
Publication of KR20240090982A publication Critical patent/KR20240090982A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020247017445A 2021-10-25 2022-10-25 이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도 Pending KR20240090982A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163271411P 2021-10-25 2021-10-25
US63/271,411 2021-10-25
PCT/CN2022/127414 WO2023072085A1 (zh) 2021-10-25 2022-10-25 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途

Publications (1)

Publication Number Publication Date
KR20240090982A true KR20240090982A (ko) 2024-06-21

Family

ID=86159046

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020247017445A Pending KR20240090982A (ko) 2021-10-25 2022-10-25 이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도
KR1020247017446A Pending KR20240090983A (ko) 2021-10-25 2022-10-25 신경 복원 촉진에 사용되는 이소로이폴린 및 그 유도체의 용도

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020247017446A Pending KR20240090983A (ko) 2021-10-25 2022-10-25 신경 복원 촉진에 사용되는 이소로이폴린 및 그 유도체의 용도

Country Status (7)

Country Link
US (2) US20240415859A1 (cg-RX-API-DMAC7.html)
EP (2) EP4424695A4 (cg-RX-API-DMAC7.html)
JP (2) JP2024539499A (cg-RX-API-DMAC7.html)
KR (2) KR20240090982A (cg-RX-API-DMAC7.html)
CN (2) CN118215669A (cg-RX-API-DMAC7.html)
TW (1) TWI898161B (cg-RX-API-DMAC7.html)
WO (2) WO2023072085A1 (cg-RX-API-DMAC7.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045072A (zh) * 2007-05-08 2007-10-03 胡军 山香圆叶提取物及其医药用途
CN102617659A (zh) * 2012-03-09 2012-08-01 中国烟草总公司郑州烟草研究院 α-紫罗兰醇葡糖苷的合成方法及其在卷烟中的加香应用
CN102617658B (zh) * 2012-03-09 2014-08-20 中国烟草总公司郑州烟草研究院 β-紫罗兰醇-β-D-葡糖苷的制备方法及其在烟草加香中的应用
CN106167508A (zh) * 2016-07-13 2016-11-30 上海应用技术学院 一种具有紫罗兰香味的葡萄糖苷化合物及其制备方法

Also Published As

Publication number Publication date
JP2024541121A (ja) 2024-11-06
US20240415859A1 (en) 2024-12-19
TW202320806A (zh) 2023-06-01
CN118215669A (zh) 2024-06-18
KR20240090983A (ko) 2024-06-21
EP4424694A1 (en) 2024-09-04
TWI898161B (zh) 2025-09-21
WO2023072069A1 (zh) 2023-05-04
US20250255893A1 (en) 2025-08-14
CN118139869A (zh) 2024-06-04
TW202317142A (zh) 2023-05-01
EP4424695A4 (en) 2025-10-22
EP4424695A1 (en) 2024-09-04
WO2023072085A1 (zh) 2023-05-04
JP2024539499A (ja) 2024-10-28
EP4424694A4 (en) 2026-03-11

Similar Documents

Publication Publication Date Title
US20170349575A1 (en) Novel chemokine cxcr1 and cxcr2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies
CN117337289A (zh) 用于治疗脑病症的四环化合物
CN118139869A (zh) 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途
JP2024541121A5 (cg-RX-API-DMAC7.html)
CN102389434B (zh) 一种治疗缺血性脑血管病的药物组合物及其制备方法
JP2005505548A (ja) 神経細胞変性の病気の治療のためのβ−アドレナリン受容体拮抗薬を使用する方法
CN113603570B (zh) 一种益母草碱冰片衍生物、制备方法及其应用
CN118613258A (zh) 8-甲基-8-氮杂双环[3.2.1]辛-3-基3-羟基-2-苯基丙酸酯的酯
US20180289655A1 (en) Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases
CN120053443B (zh) 金雀花碱-n-亚甲基-(5,7,4’-三羟基)异黄酮在制备治疗脑梗药物的应用
JP2024539499A5 (cg-RX-API-DMAC7.html)
RU2814327C1 (ru) ПРИМЕНЕНИЕ СУЛЬФАТНЫХ СОЛЕЙ N-(3-(4-(3-(ДИИЗОБУТИЛАМИНО)ПРОПИЛ)ПИПЕРАЗИН-1-ИЛ)ПРОПИЛ)-1Н-БЕНЗО[d]ИМИДАЗОЛ-2-АМИНА И ИХ СОЛЬВАТОВ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ДВИГАТЕЛЬНЫХ НЕЙРОНОВ И НАРУШЕНИЙ НЕРВНО-МЫШЕЧНЫХ СОЕДИНЕНИЙ
CN119569643B (zh) 一种二级胺类局部麻醉药及其应用
CN116987091B (zh) 用于治疗癫痫发作疾病的药物及其制备方法
CN118384156A (zh) 一种火把花衍生物ri-695在制备治疗阿尔兹海默症药物中的应用
Zhu Research progress on brain-derived neurotrophic factor in ocular diseases
CN120501080A (zh) 一种卒中后抑郁小鼠模型的构建方法
US9918996B2 (en) Methods of using qiapine
TWI230064B (en) Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
EP4716535A2 (en) Boldine to reduce muscle atrophy and promote neuromuscular recovery
Wang et al. Mesenchymal stem cell therapy in autoimmune eye diseases: Focus on dry eye diseases and autoimmune uveitis
CN121248702A (zh) 一氧化氮供体型羊毛甾醇衍生物及其制备方法和应用
JP2007502863A (ja) 認知障害の治療および認知改善の方法
CN115925628A (zh) 青藤碱酯类衍生物及其制备方法和应用、镇痛药物
Raikova et al. GILLES DE LA TOURETTE'S SYNDROME: CLINICAL FEATURES, DIAGNOSIS, MODERN TREATMENT METHODS

Legal Events

Date Code Title Description
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902